title: Phase II study of high dose ifosfamide plus mesna in inoperable non small cell lung carcinoma.
authors.affiliation: Comité de Pathologie thoracique, Institut Gustave-Roussy, Villejuif, France.
authors.forename: Z
authors.initials: Z
authors.lastname: Pastran
authors.forename: T
authors.initials: T
authors.lastname: le Chevalier
authors.forename: P
authors.initials: P
authors.lastname: Baldeyrou
authors.forename: M
authors.initials: M
authors.lastname: Spielmann
authors.forename: R
authors.initials: R
authors.lastname: Arriagada
authors.forename: J P
authors.initials: JP
authors.lastname: Droz
authors.forename: J
authors.initials: J
authors.lastname: Rouesse
mesh_terms: D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007069:Ifosfamide / Q000008:administration & dosage; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D015080:Mesna / Q000627:therapeutic use; D008875:Middle Aged
chemical_list: D015080:Mesna; D007069:Ifosfamide